logo
Sign in

WYPH Stock Price, Chart, Stats & News

WayPoint Biomedical Holdings, Inc.
Save

WayPoint Biomedical Holdings, Inc. (WYPH) does not currently pay a dividend.

16,620
Market cap
Current P/E
Forward P/E

WYPH chart

About

Industrials
Sector
Specialty Business Services
Industry

WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction.

Similar securities

Based on sector and market capitalization

Report issue